Nektar Investigative Site

Toronto, Ontario M4W 2N2

0 studies enrolling now · 1 studies all time

What they study most

Moderate to Severe Atopic Dermatitis

Studies at this site

• A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Adult Patients With Moderate-to-Severe Atopic Dermatitis — Running, not enrolling